To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZFP64TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
282 supporting clones for gene ZFP64 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC012759 Lymph, Burkitt lymphoma .a 1 to 3255 1 to 3254 S451N tiling clone, available from MGC, AAA   3254/3254
(100 %)
7 diff
(99.8 %id)
BC041622 Lymph, Burkitt lymphoma .a 1 to 3255 1 to 3254   available from MGC, AAA   3254/3254
(100 %)
7 diff
(99.8 %id)
NM_018197.2   .a 1 to 3255 1 to 3255 exact RefSeq, AAA   3255/3255
(100 %)
0 diff
(100 %id)
AK001596   .a 211 to 3260 1 to 3048 S451N tiling clone, available from FLJ,   3048/3048
(100 %)
11 diff
(99.7 %id)
AU130765   .a 212 to 1030 2 to 820   capped   819/821
(99 %)
11 diff
(98.7 %id)
BX353400 Neuroblastoma Cot 25-normalized .a 217 to 1111 1 to 896       896/897
(99 %)
5 diff
(99.5 %id)
BX336460 Placenta Cot 25-normalized .a 278 to 1053 1 to 772       719/792
(90 %)
49 diff
(93.9 %id)
TI_1948140522   .a 349 to 1378 126 to 1161       1036/1333
(77 %)
54 diff
(96.0 %id)
TI_1948140855   .a 349 to 1395 125 to 1161       1037/1332
(77 %)
42 diff
(96.9 %id)
TI_1948141194   .a 349 to 1391 135 to 1189       1055/1380
(76 %)
50 diff
(96.4 %id)
TI_1948141531   .a 349 to 1397 120 to 1171       1052/1362
(77 %)
33 diff
(97.6 %id)
BX425223 neuroblastoma .a 2324 to 3263 1 to 940   tiling clone,   940/940
(100 %)
6 diff
(99.4 %id)
H91231 liver and spleen .a 2324 to 2632 1 to 312       312/347
(89 %)
11 diff
(96.9 %id)
BX372604 Neuroblastoma Cot 25-normalized .a 2349 to 3244 922 to 13       910/925
(98 %)
0 diff
(100 %id)
BX330174 Placenta Cot 25-normalized .a 2382 to 3241 859 to 1       859/869
(98 %)
20 diff
(97.7 %id)
BI223082 cervical carcinoma cell line, cervix .a 2418 to 3112 1 to 697       697/697
(100 %)
6 diff
(99.2 %id)
BI223970 cervical carcinoma cell line, cervix .a 2418 to 3191 1 to 781   tiling clone,   781/781
(100 %)
15 diff
(98.1 %id)
BM783629 stomach .a 2663 to 3259 1 to 597       597/597
(100 %)
0 diff
(100 %id)
AU152662   .a 2732 to 3260 528 to 1       528/531
(99 %)
17 diff
(96.8 %id)
CK904007 Islets of Langerhans, Pancreas .a 2742 to 3262 543 to 23   AAA   521/521
(100 %)
1 diff
(99.9 %id)
BF059485 pooled germ cell tumors .a 2771 to 3255 486 to 1       486/486
(100 %)
5 diff
(99.0 %id)
AV661106 corresponding non cancerous liver tissue .a 2806 to 3195 1 to 390     Submitted on the opposite strand 390/390
(100 %)
0 diff
(100 %id)
AI276628 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2806 to 3254 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AI144452 heart .a 2821 to 3263 443 to 2       442/443
(99 %)
0 diff
(100 %id)
H91177 liver and spleen .a 2887 to 3247 365 to 1       365/365
(100 %)
6 diff
(98.4 %id)
NM_199426.1   .b 1 to 3249 1 to 3249 exact RefSeq, AAA   3249/3249
(100 %)
0 diff
(100 %id)
DA253844 caudate nucleus .b 210 to 790 2 to 582   tiling clone, capped   581/581
(100 %)
1 diff
(99.9 %id)
DA505465 brain .b 210 to 772 2 to 567   capped   566/566
(100 %)
4 diff
(99.3 %id)
DR002741 fetal brain .b 222 to 928 8 to 715       708/715
(99 %)
9 diff
(98.8 %id)
DA287050 corpus callosum .b 232 to 807 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BC031524 Skin, melanotic melanoma. .b 236 to 3249 1 to 3011 L417R D418C A419Q K420E K421E ... tiling clone, available from MGC, AAA   3011/3011
(100 %)
4 diff
(99.9 %id)
CO247946 Chondrosarcoma Lung Metastasis cell lines, lung .b 252 to 855 1 to 602       602/818
(73 %)
11 diff
(98.7 %id)
DA434283 tongue, tumor tissue .b 258 to 787 2 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
DB251351 uterus .b 260 to 796 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA443791 tongue, tumor tissue .b 267 to 835 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA566032 heart .b 267 to 841 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA621909 Kidney .b 267 to 802 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DB002055 breast, tumor tissue .b 267 to 822 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA782337 brain .b 268 to 826 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AL556456 placenta .b 271 to 1280 1 to 1011       1011/1011
(100 %)
4 diff
(99.7 %id)
CN426533 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 299 to 1008 1 to 710       710/710
(100 %)
0 diff
(100 %id)
DA446863 tongue, tumor tissue .b 338 to 923 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
CD629039   .b 397 to 1129 739 to 9       731/739
(98 %)
4 diff
(99.5 %id)
AW363135 colon .b 531 to 1124 26 to 619       594/619
(95 %)
6 diff
(99.1 %id)
BE612520 adenocarcinoma, ovary .b 701 to 1411 1 to 718   AAA   718/1010
(71 %)
24 diff
(97.7 %id)
CN426532 embryonic stem cells, cell lines H1, H7, andH9 .b 736 to 1373 1 to 638       638/638
(100 %)
0 diff
(100 %id)
CF786014 mixed .b 864 to 1590 1 to 721       721/811
(88 %)
17 diff
(98.0 %id)
BQ432320 melanotic melanoma, skin .b 948 to 1765 1 to 820       820/889
(92 %)
8 diff
(99.2 %id)
DA519493 brain .b 973 to 1507 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BE818754 breast_normal .b 1136 to 1322 200 to 13       188/200
(94 %)
0 diff
(100 %id)
BY796672 eye .b 1211 to 1791 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA349414 substantia nigra .b 1284 to 1842 2 to 561   capped   560/560
(100 %)
4 diff
(99.3 %id)
TI_1948141532   .b 1368 to 2388 1140 to 128       1013/1359
(74 %)
0 diff
(100 %id)
TI_1948141195   .b 1394 to 2388 1117 to 129       989/1351
(73 %)
0 diff
(100 %id)
TI_1948140523   .b 1400 to 2388 1106 to 129       978/1275
(76 %)
0 diff
(100 %id)
BG291035 bladder, transitional cell papilloma, cell line .b 1450 to 2215 1 to 771   tiling clone,   771/866
(89 %)
19 diff
(97.9 %id)
TI_1948140856   .b 1469 to 2388 1049 to 130       920/1380
(66 %)
0 diff
(100 %id)
BE895570 melanotic melanoma, skin .b 1497 to 2282 1 to 792       792/927
(85 %)
70 diff
(92.5 %id)
TI_1948141196   .b 1583 to 2388 938 to 134       805/1411
(57 %)
0 diff
(100 %id)
TI_1948140524   .b 1621 to 2388 909 to 140       770/1400
(55 %)
0 diff
(100 %id)
BG716031 brain, hypothalamus .b 1642 to 2374 1 to 738       738/742
(99 %)
26 diff
(96.5 %id)
TI_1948140857   .b 1720 to 2388 809 to 140       670/1392
(48 %)
0 diff
(100 %id)
BQ440976 melanotic melanoma, skin .b 1747 to 2595 14 to 874       861/932
(92 %)
11 diff
(98.9 %id)
CX761284 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1748 to 2459 1 to 711     Submitted on the opposite strand 711/718
(99 %)
4 diff
(99.5 %id)
BF922717 nervous_tumor .b 1750 to 1865 139 to 22     Submitted on the opposite strand 118/139
(84 %)
0 diff
(100 %id)
BI260505 cervical carcinoma cell line, cervix .b 1754 to 2615 1 to 859       859/862
(99 %)
12 diff
(98.7 %id)
TI_1948141533   .b 1764 to 2388 761 to 133       629/1418
(44 %)
0 diff
(100 %id)
BF342415 brain, glioblastoma with EGFR amplification .b 1856 to 2484 1 to 631       631/1005
(62 %)
14 diff
(98.7 %id)
AK024671   .b 1880 to 2977 1 to 1098   tiling clone, available from FLJ, AAA   1098/1098
(100 %)
0 diff
(100 %id)
BG254648 adenocarcinoma, cell line, Prostate .b 1880 to 2586 1 to 703       703/705
(99 %)
17 diff
(97.6 %id)
TI_1948140478   .b 1892 to 2387 564 to 67       498/1273
(39 %)
0 diff
(100 %id)
CK904008 Islets of Langerhans, Pancreas .b 2108 to 2705 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BM053113 Islets of Langerhans, Pancreas .b 2124 to 2700 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BF381546 brain, primitive neuroectoderm .b 2138 to 2865 1 to 703       703/872
(80 %)
37 diff
(95.8 %id)
BF247213 hypernephroma, Kidney .b 2138 to 2764 1 to 630       630/908
(69 %)
42 diff
(95.4 %id)
BG531975 embryonal carcinoma, testis .b 2153 to 2851 1 to 697       697/1008
(69 %)
51 diff
(95.0 %id)
BF690863 melanotic melanoma, high MDR, skin .b 2160 to 2791 1 to 622       622/1175
(52 %)
25 diff
(97.9 %id)
AL578705 placenta .b 2178 to 3216 1027 to 1       1027/1037
(99 %)
19 diff
(98.2 %id)
BF882178 lung_tumor .b 2304 to 2637 333 to 1     Submitted on the opposite strand 333/333
(100 %)
4 diff
(98.8 %id)
BM760295 lymph node, stomach .b 2304 to 2903 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BM781456 lymph node, stomach .b 2304 to 2934 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BM781467 lymph node, stomach .b 2304 to 2941 1 to 638       638/638
(100 %)
0 diff
(100 %id)
AA378808 synovial membrane .b 2312 to 2681 1 to 369       369/369
(100 %)
6 diff
(98.4 %id)
BX091765 liver and spleen .b 2318 to 2825 1 to 508       508/508
(100 %)
0 diff
(100 %id)
AI439372 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2407 to 2833 427 to 1       427/427
(100 %)
0 diff
(100 %id)
BI258700 cervical carcinoma cell line, cervix .b 2547 to 2839 9 to 301   AAA   293/301
(97 %)
6 diff
(98.1 %id)
AW613100 colon, moderately-differentiated adenocarcinoma .b 2846 to 3249 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BE708271 head_neck .b 2879 to 3037 162 to 4       159/162
(98 %)
0 diff
(100 %id)
R35551 placenta .b 2891 to 3210 1 to 327       327/330
(99 %)
9 diff
(97.3 %id)
BI763394 pooled colon, kidney, stomach .b 2909 to 3249 1 to 341   AAA   341/341
(100 %)
2 diff
(99.5 %id)
TI_57150063   .b 2909 to 3249 71 to 411   AAA   341/411
(82 %)
6 diff
(98.6 %id)
AA789013 parathyroid gland, parathyroid tumor .b 3054 to 3255 208 to 7   tiling clone,   202/208
(97 %)
0 diff
(100 %id)
NM_199427.2   .c 1 to 2832 1 to 2832 exact RefSeq, AAA   2832/2832
(100 %)
0 diff
(100 %id)
BE296705 muscle, rhabdomyosarcoma .c 21 to 581 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BE269094 Burkitt lymphoma, lymph .c 21 to 650 1 to 643       643/650
(98 %)
31 diff
(95.3 %id)
BE396894 Burkitt lymphoma, lymph .c 21 to 650 1 to 632   tiling clone,   632/740
(85 %)
9 diff
(98.8 %id)
BE513257 Burkitt lymphoma, lymph .c 22 to 759 1 to 737       737/788
(93 %)
14 diff
(98.3 %id)
DA389360 thalamus .c 198 to 726 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA289359 hippocampus .c 203 to 751 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA122190 cerebellum .c 204 to 769 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA016501 adrenal gland .c 208 to 767 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA447617 tongue, tumor tissue .c 208 to 776 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA450387 tongue, tumor tissue .c 208 to 772 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA750967   .c 208 to 774 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA769461 brain .c 208 to 767 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA772705 brain .c 208 to 780 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA801441 brain .c 208 to 781 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA818806   .c 208 to 769 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB080941 testis .c 208 to 771 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB275408 uterus .c 208 to 780 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA771003 brain .c 209 to 784 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA451943 tongue, tumor tissue .c 210 to 789 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA780719 brain .c 214 to 781 2 to 572   capped   571/572
(99 %)
4 diff
(99.4 %id)
BC021087 Lymph, Burkitt lymphoma .c 289 to 2832 10 to 2553 R521C tiling clone, available from MGC, AAA   2544/2544
(100 %)
1 diff
(100.0 %id)
TI_1948095748   .c 349 to 1264 140 to 1056       917/1304
(70 %)
16 diff
(98.8 %id)
BT009760   .c 350 to 2287 1 to 1938 R521C     1938/1938
(100 %)
1 diff
(100.0 %id)
BE048114 brain, tumor, 5 pooled (see description) .c 472 to 918 1 to 447       447/448
(99 %)
8 diff
(98.3 %id)
AW673278 cervix .c 637 to 965 1 to 329       329/331
(99 %)
24 diff
(92.8 %id)
DA812644 ovary, tumor tissue .c 1051 to 1776 2 to 726   capped   725/725
(100 %)
3 diff
(99.6 %id)
DA943534 Spleen .c 1174 to 1741 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
AI829089 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1204 to 1875 671 to 1       673/671
(100 %)
6 diff
(99.2 %id)
AW958380   .c 1215 to 1722 1 to 505       505/523
(96 %)
18 diff
(96.6 %id)
AI863429 brain, tumor, 5 pooled (see description) .c 1225 to 1875 649 to 2       648/649
(99 %)
4 diff
(99.4 %id)
AI922955 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1245 to 1857 612 to 1       612/613
(99 %)
4 diff
(99.4 %id)
CF264908 Brain glioblastoma .c 1267 to 1867 1 to 601       601/601
(100 %)
3 diff
(99.6 %id)
AW675627 cervix .c 1304 to 1875 571 to 1       571/571
(100 %)
2 diff
(99.7 %id)
BF437315 Prostate .c 1328 to 1867 540 to 1       540/540
(100 %)
2 diff
(99.7 %id)
AW058023 thymus, pooled .c 1344 to 1857 508 to 1       508/564
(90 %)
31 diff
(94.6 %id)
AI472968 pooled .c 1379 to 1866 488 to 1       488/488
(100 %)
19 diff
(96.2 %id)
AI379442 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1383 to 1857 475 to 1       475/486
(97 %)
3 diff
(99.4 %id)
AW139935   .c 1386 to 1874 489 to 1       489/489
(100 %)
1 diff
(99.8 %id)
AI493118 Kidney .c 1387 to 1875 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AI288648 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1395 to 1875 481 to 1       481/481
(100 %)
1 diff
(99.8 %id)
AI204221   .c 1397 to 1857 462 to 1       462/464
(99 %)
4 diff
(99.2 %id)
BE542945 cervix .c 1419 to 1845 1 to 427       427/427
(100 %)
0 diff
(100 %id)
AA781855   .c 1432 to 1873 442 to 2       441/442
(99 %)
3 diff
(99.4 %id)
AA455072 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1434 to 1855 420 to 1       420/421
(99 %)
6 diff
(98.6 %id)
AW139348   .c 1502 to 1874 377 to 1       373/377
(98 %)
0 diff
(100 %id)
AI393154 pooled .c 1566 to 1857 292 to 1       292/292
(100 %)
0 diff
(100 %id)
TI_1948095749   .c 1577 to 2286 836 to 125       712/1283
(55 %)
0 diff
(100 %id)
AA993912 pooled .c 1631 to 1733 103 to 1       103/103
(100 %)
0 diff
(100 %id)
AI204542   .c 1631 to 1733 103 to 1       103/103
(100 %)
2 diff
(98.1 %id)
AI261964 adenocarcinoma, colon .c 1631 to 1733 103 to 1       103/103
(100 %)
0 diff
(100 %id)
AA134758   .c 1652 to 1869 1 to 221       221/223
(99 %)
5 diff
(97.8 %id)
DB372085 ovary, tumor tissue .c 2271 to 2832 562 to 1       562/564
(99 %)
14 diff
(97.6 %id)
NM_022088.4   .d 1 to 3093 1 to 3093 exact RefSeq, AAA   3093/3093
(100 %)
0 diff
(100 %id)
DA530964 brain .d 208 to 780 2 to 574   tiling clone, capped   573/573
(100 %)
2 diff
(99.7 %id)
DA871655 Prostate .d 212 to 746 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
BU175482 large cell carcinoma, lung .d 226 to 1081 12 to 871       860/875
(98 %)
16 diff
(98.2 %id)
DB258393 uterus .d 258 to 813 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB269175 uterus .d 262 to 817 2 to 561   capped   560/560
(100 %)
4 diff
(99.3 %id)
DA939963 Spleen .d 271 to 849 8 to 587   capped   580/580
(100 %)
2 diff
(99.7 %id)
AK001744   .d 274 to 2816 1 to 2543 exact tiling clone, available from FLJ,   2543/2543
(100 %)
0 diff
(100 %id)
AU133370   .d 275 to 1124 2 to 848   capped   847/847
(100 %)
10 diff
(98.9 %id)
CN426535 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 422 to 1193 1 to 772       772/772
(100 %)
5 diff
(99.4 %id)
BM012126 brain, neuroblastoma, cell line .d 521 to 1343 1 to 826       826/827
(99 %)
20 diff
(97.6 %id)
TI_59381326   .d 521 to 1343 98 to 923       826/827
(99 %)
20 diff
(97.6 %id)
AU154718   .d 2331 to 2816 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AL529212 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 1 to 868 1 to 867   tiling clone,   867/867
(100 %)
3 diff
(99.7 %id)
AL563389 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 901 to 1786 886 to 1   tiling clone,   886/886
(100 %)
10 diff
(98.9 %id)
CV574281 cornea, eye .f 1 to 618 1 to 619   tiling clone,   619/619
(100 %)
1 diff
(99.9 %id)
DA731353   .f 160 to 987 2 to 831   capped   830/851
(97 %)
20 diff
(97.7 %id)
AK022690   .f 161 to 2051 1 to 1891 exact tiling clone, available from FLJ,   1891/1891
(100 %)
2 diff
(99.9 %id)
AU125573   .f 162 to 1024 2 to 859   capped   858/858
(100 %)
17 diff
(98.1 %id)
BQ955451 large cell carcinoma, lung .f 179 to 480 1 to 305       305/311
(98 %)
5 diff
(98.4 %id)
DA695188   .f 322 to 908 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA037770   .f 342 to 865 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
DA951797 Spleen .f 342 to 891 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AA724492 parathyroid gland, parathyroid tumor .f 1269 to 1617 1 to 349     Submitted on the opposite strand 349/349
(100 %)
1 diff
(99.8 %id)
AI922252 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f 1269 to 1729 1 to 461     Submitted on the opposite strand 461/461
(100 %)
2 diff
(99.6 %id)
BF941750 fibrotheoma, ovary .f 1269 to 1627 1 to 359     Submitted on the opposite strand 359/359
(100 %)
1 diff
(99.8 %id)
BF196346 fibrotheoma, ovary .f 1269 to 1797 1 to 529     Submitted on the opposite strand 529/529
(100 %)
0 diff
(100 %id)
TI_154002109   .f 1269 to 1881 83 to 695     Submitted on the opposite strand 613/696
(88 %)
4 diff
(99.5 %id)
AA740955 2 pooled tumors (clear cell type), Kidney .f 1270 to 1685 1 to 415     Submitted on the opposite strand 415/415
(100 %)
4 diff
(99.1 %id)
BX093417 parathyroid gland, parathyroid tumor .f 1271 to 1686 416 to 1     Submitted on the opposite strand 416/416
(100 %)
0 diff
(100 %id)
AA860117   .f 1273 to 1758 1 to 480     Submitted on the opposite strand 480/480
(100 %)
10 diff
(98.0 %id)
BF435964 pooled .f 1284 to 1697 1 to 414     Submitted on the opposite strand 414/414
(100 %)
0 diff
(100 %id)
AW665114 pooled .f 1286 to 1589 1 to 304     Submitted on the opposite strand 304/304
(100 %)
3 diff
(99.1 %id)
AI479976 anaplastic oligodendroglioma, brain .f 1287 to 1735 1 to 449     Submitted on the opposite strand 449/449
(100 %)
0 diff
(100 %id)
AA854646 parathyroid gland, parathyroid tumor .f 1296 to 1653 1 to 357     Submitted on the opposite strand 357/357
(100 %)
4 diff
(98.9 %id)
AA888839   .f 1296 to 1790 1 to 493     Submitted on the opposite strand 493/493
(100 %)
3 diff
(99.4 %id)
AI092718 parathyroid gland, parathyroid tumor .f 1296 to 1653 1 to 358     Submitted on the opposite strand 358/358
(100 %)
0 diff
(100 %id)
AI568675 B-cell, chronic lymphotic leukemia .f 1296 to 1735 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AI566265 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f 1296 to 1671 1 to 376     Submitted on the opposite strand 376/376
(100 %)
0 diff
(100 %id)
AI817753 anaplastic oligodendroglioma, brain .f 1296 to 1768 1 to 473     Submitted on the opposite strand 473/473
(100 %)
0 diff
(100 %id)
AW439983 2 pooled tumors (clear cell type), Kidney .f 1296 to 1637 1 to 340     Submitted on the opposite strand 340/340
(100 %)
2 diff
(99.5 %id)
AW131538 brain, medulloblastoma .f 1302 to 1759 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
AA935921 carcinoid, lung .f 1311 to 1682 1 to 371     Submitted on the opposite strand 371/371
(100 %)
1 diff
(99.8 %id)
AW084473 colon, colonic mucosa from 3 patients with Crohn'sdisease .f 1320 to 1745 1 to 428     Submitted on the opposite strand 428/428
(100 %)
9 diff
(97.9 %id)
BG149485 carcinoid, lung .f 1430 to 1660 223 to 458     Submitted on the opposite strand 236/458
(51 %)
6 diff
(98.7 %id)
AU149207   .f 1466 to 2051 585 to 1       585/585
(100 %)
7 diff
(98.9 %id)
TI_159688430   .f 1467 to 2233 875 to 109   AAA   767/994
(77 %)
2 diff
(99.8 %id)
AA370730 Prostate .f 1533 to 1688 1 to 156       156/156
(100 %)
0 diff
(100 %id)
AA370716 Prostate .f 1548 to 1858 1 to 311       311/311
(100 %)
1 diff
(99.7 %id)
BQ000987 lung, Metastatic Chondrosarcoma .f 1669 to 2233 583 to 19   AAA   565/565
(100 %)
0 diff
(100 %id)
AU149511   .f 1771 to 2233 463 to 1       463/471
(98 %)
0 diff
(100 %id)
CF595769 Stomach, adenocarcinoma .f 1840 to 2233 1 to 394   AAA   394/394
(100 %)
2 diff
(99.5 %id)
CN276408 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1904 to 2234 334 to 4   tiling clone, Submitted on the opposite strand 331/334
(99 %)
0 diff
(100 %id)
AK222712 colon .g 1 to 1832 2 to 1835 S240G tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1835/1835
(100 %)
9 diff
(99.6 %id)
BX353541 Neuroblastoma Cot 25-normalized .g 12 to 1046 1 to 1032   tiling clone,   1032/1032
(100 %)
11 diff
(99.0 %id)
BQ424100 eye, retinoblastoma .g 15 to 918 1 to 906       906/927
(97 %)
14 diff
(98.5 %id)
AL556014 placenta .g 18 to 863 1 to 847       847/862
(98 %)
4 diff
(99.6 %id)
AL602736 human skeletal muscle .g 23 to 621 1 to 599       599/599
(100 %)
0 diff
(100 %id)
DA516554 brain .g 24 to 519 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
DB161562 thymus .g 24 to 611 2 to 591   capped   590/590
(100 %)
3 diff
(99.5 %id)
DA788355 brain .g 26 to 590 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BM048383 carcinoma, cell line, Prostate .g 35 to 654 1 to 625       625/745
(83 %)
29 diff
(96.2 %id)
BE887132 leiomyosarcoma, uterus .g 36 to 822 1 to 796       796/822
(96 %)
36 diff
(95.7 %id)
BQ943289 carcinoma, cell line, Prostate .g 37 to 776 1 to 742       742/948
(78 %)
26 diff
(97.3 %id)
DN995854 breast cancer, Mammary gland (cancer tissue) .g 45 to 655 26 to 635       610/635
(96 %)
6 diff
(99.1 %id)
BQ895871 carcinoma, cell line, Prostate .g 50 to 875 1 to 844       844/924
(91 %)
72 diff
(92.3 %id)
CF993748 Human Placenta, placenta .g 52 to 830 28 to 811       784/816
(96 %)
15 diff
(98.2 %id)
DA299117 hippocampus .g 54 to 629 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA445744 tongue, tumor tissue .g 54 to 280 2 to 228   capped   227/227
(100 %)
0 diff
(100 %id)
DA741348   .g 54 to 569 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
DB272112 uterus .g 54 to 621 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA686525   .g 55 to 597 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA714115   .g 57 to 613 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA015313 adrenal gland .g 59 to 629 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA202800 brain .g 59 to 642 2 to 585   capped   584/584
(100 %)
4 diff
(99.4 %id)
DA703175   .g 59 to 517 8 to 466   capped   459/459
(100 %)
0 diff
(100 %id)
DA793244 brain .g 59 to 562 2 to 505   capped   504/507
(99 %)
2 diff
(99.7 %id)
DB115427 thymus .g 59 to 579 2 to 522   capped   521/521
(100 %)
1 diff
(99.9 %id)
DA444467 tongue, tumor tissue .g 60 to 629 2 to 571   capped   570/571
(99 %)
1 diff
(99.9 %id)
DA499454 brain .g 60 to 639 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA683837   .g 60 to 384 2 to 326   capped   325/325
(100 %)
0 diff
(100 %id)
DA118759 cerebellum .g 61 to 600 2 to 545   capped   544/544
(100 %)
4 diff
(99.3 %id)
DA436607 tongue, tumor tissue .g 61 to 646 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA752869   .g 61 to 620 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB253841 uterus .g 61 to 618 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA598423   .g 64 to 622 15 to 573   capped   559/559
(100 %)
2 diff
(99.7 %id)
BX342005   .g 71 to 905 1 to 834       834/834
(100 %)
1 diff
(99.9 %id)
CO393448 Chondrosarcoma Lung Metastasis cell lines, lung .g 73 to 780 8 to 706       699/847
(82 %)
19 diff
(97.8 %id)
CD629036   .g 78 to 802 1 to 725       725/725
(100 %)
3 diff
(99.6 %id)
BI226541 Burkitt lymphoma, lymph .g 81 to 816 1 to 733       733/733
(100 %)
10 diff
(98.7 %id)
CD629038   .g 82 to 812 8 to 736       729/736
(99 %)
10 diff
(98.7 %id)
BG335464 choriocarcinoma, placenta .g 83 to 789 1 to 706       706/712
(99 %)
10 diff
(98.6 %id)
BG335311 choriocarcinoma, placenta .g 83 to 852 1 to 764       764/827
(92 %)
18 diff
(97.9 %id)
BE514906 adenocarcinoma cell line, ovary .g 87 to 780 1 to 688       688/748
(91 %)
12 diff
(98.4 %id)
DA491046 brain .g 90 to 665 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CN426534 embryonic stem cells, cell lines H1, H7, andH9 .g 99 to 406 1 to 308       308/308
(100 %)
3 diff
(99.1 %id)
BE270889 Burkitt lymphoma, lymph .g 101 to 877 1 to 773   available from MGC,   773/813
(95 %)
9 diff
(98.9 %id)
TI_1948140854   .g 142 to 591 125 to 575       451/1408
(32 %)
18 diff
(98.8 %id)
TI_1948141193   .g 142 to 654 124 to 638       515/1473
(34 %)
11 diff
(99.3 %id)
TI_1948141530   .g 142 to 654 121 to 633       511/1313
(38 %)
16 diff
(98.8 %id)
CV028131 mixed .g 143 to 798 1 to 656       656/656
(100 %)
1 diff
(99.9 %id)
BE269381 Burkitt lymphoma, lymph .g 151 to 747 50 to 671       593/671
(88 %)
55 diff
(91.9 %id)
CV027583 mixed .g 189 to 582 47 to 439       399/439
(90 %)
9 diff
(98.0 %id)
CD629037   .g 233 to 913 705 to 25       681/705
(96 %)
1 diff
(99.9 %id)
BF762408 colon_est .g 360 to 559 218 to 22     Submitted on the opposite strand 197/218
(90 %)
10 diff
(95.5 %id)
FN123621 breast carcinoma .g 471 to 577 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
BF799161 colon_ins .g 900 to 1185 287 to 1     Submitted on the opposite strand 287/302
(95 %)
5 diff
(98.4 %id)
AA379460 skin .g 1007 to 1309 1 to 303       303/306
(99 %)
1 diff
(99.7 %id)
AA226755 brain, neuroepithelial cells .g 1042 to 1374 1 to 329       329/332
(99 %)
7 diff
(97.9 %id)
CA314246 Human Lung Epithelial cells, lung .g 1516 to 1732 1 to 217   AAA Submitted on the opposite strand 217/217
(100 %)
9 diff
(95.9 %id)
DA651889   .h 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
BG823768 adenocarcinoma cell line, colon .h 127 to 1004 1 to 876   tiling clone,   876/1089
(80 %)
24 diff
(97.8 %id)
AW166933 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 663 to 1264 602 to 1   tiling clone,   602/602
(100 %)
13 diff
(97.9 %id)
CB120214 Liver .h 1185 to 1712 1 to 528   tiling clone,   528/528
(100 %)
0 diff
(100 %id)
BI461450 testis .i 1 to 783 1 to 783   tiling clone,   783/784
(99 %)
9 diff
(98.9 %id)
BG722562 testis .i 60 to 834 1 to 768   tiling clone,   771/772
(99 %)
28 diff
(96.4 %id)
AA447205   .i 716 to 1160 445 to 1   tiling clone,   445/445
(100 %)
0 diff
(100 %id)
DA600061   .j 1 to 566 2 to 567   tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
CB997078 placenta, pre-eclamptic placenta .j 11 to 539 28 to 560       533/832
(64 %)
18 diff
(97.9 %id)
CB993576 placenta, pre-eclamptic placenta .j 11 to 556 28 to 581       554/874
(63 %)
17 diff
(98.1 %id)
CB993745 placenta, pre-eclamptic placenta .j 11 to 724 28 to 749 A169P S173G P188A Y189V K190P ... tiling clone,   722/813
(88 %)
22 diff
(97.3 %id)
CB991208 placenta, pre-eclamptic placenta .j 11 to 725 28 to 744 I182N P188A R199P N200Q S201L ... tiling clone,   717/803
(89 %)
12 diff
(98.6 %id)
BP871720 embryonal kidney .j 13 to 595 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AA442183   .k 1 to 493 1 to 493   tiling clone,   493/493
(100 %)
0 diff
(100 %id)
CN273451 embryonic stem cells, DMSO-treated H9 cellline .k 30 to 647 1 to 618   tiling clone,   618/618
(100 %)
5 diff
(99.2 %id)
AA442080   .k 651 to 1106 457 to 3   tiling clone,   455/457
(99 %)
1 diff
(99.8 %id)
DA449897 tongue, tumor tissue .l 1 to 578 2 to 579 exact tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
DA726695   .m 1 to 539 2 to 540   tiling clone, capped   539/539
(100 %)
0 diff
(100 %id)
DA715409   .m 11 to 571 2 to 568 A3C S4E S5Q E6L G7R ... tiling clone, capped   567/571
(99 %)
7 diff
(98.8 %id)
CN309657 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 1 to 710 1 to 710 exact tiling clone,   710/710
(100 %)
1 diff
(99.9 %id)
BF308588 muscle, rhabdomyosarcoma .o 1 to 806 1 to 789 F69L V70Y S71R E72R E73K ... tiling clone,   789/871
(90 %)
30 diff
(96.6 %id)
BF308577 muscle, rhabdomyosarcoma .o 1 to 772 1 to 764 F69L V70Y S71R E72R E73K ... tiling clone,   764/786
(97 %)
15 diff
(98.1 %id)
DA442984 tongue, tumor tissue .p 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BP218306 caudate nucleus .p 168 to 748 2 to 582   tiling clone,   581/582
(99 %)
0 diff
(100 %id)
BI197388 brain, neuroblastoma .q 1 to 514 1 to 516 T58S T63N T64S T71N F81L ... tiling clone,   516/741
(69 %)
23 diff
(96.9 %id)
CN426531 embryonic stem cells, DMSO-treated H9 cellline .r 1 to 506 6 to 511 exact tiling clone,   511/511
(100 %)
0 diff
(100 %id)
DB018337 esophageal, tumor tissue .s 1 to 569 2 to 571 E34G P35A A36G S37F E38R ... tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DA597508   .t 1 to 561 2 to 562 exact tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
DB025048 testis .u 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
4 diff
(99.3 %id)
DB058308 testis .u 4 to 276 2 to 274   capped   273/273
(100 %)
1 diff
(99.7 %id)
AI568689 B-cell, chronic lymphotic leukemia .va-u 1 to 497 497 to 1 exact tiling clone,   497/497
(100 %)
0 diff
(100 %id)
DB068365 testis .vb 1 to 534 2 to 535   tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
AI637856 pooled germ cell tumors .vc-u 1 to 446 452 to 7 exact tiling clone,   446/452
(98 %)
0 diff
(100 %id)
FN128600 breast carcinoma .vc-u 278 to 367 93 to 1     Submitted on the opposite strand 93/101
(92 %)
3 diff
(97.1 %id)
AK090547   Gene ZFP64, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
DB295516   Gene ZFP64, variant not shown         Suspected internal deletion, this clone was ignored    
DA019913   Gene ZFP64, variant not shown       capped Suspected internal deletion, this clone was ignored    
BG390882 embryonal carcinoma, cell line, testis Gene ZFP64, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BI828154 brain, medulla Gene ZFP64, variant not shown         This clone was ignored    
TI_57171542   Gene ZFP64, variant not shown         This clone was ignored    
DA778892 brain Gene ZFP64, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB371251 ovary, tumor tissue Gene ZFP64, variant not shown         Suspected internal deletion, this clone was ignored    
DA811984 ovary, tumor tissue Gene ZFP64, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI